Mediar Therapeutics

Mediar Therapeutics has been recognized as one of BioSpace's Best Places to Work for 2025! This recognition places us among the top 50 most sought-after employers in the life sciences industry, highlighting our commitment to an inclusive, innovative, and collaborative work culture. ? This recognition reflects our collective dedication to excellence and innovation. Thank you to our entire team for making Mediar such a remarkable place to work! ? #BestPlacestoWork #LifeSciences #CompanyCulture #Biospace2025 #Biotech Learn more: https://lnkd.in/gKuFq2cG

Celebrating Katherine Palu's two year anniversary at Mediar Therapeutics! Your energy, effort, and enthusiasm has made a significant impact on our team. Grateful to have you with us! Here’s to many more successful years together! ?? #EmployeeAppreciation #CompanyCulture #biotech

Happy Halloween from the Mediarite crew! ?? This afternoon, we had a great time at Mediar’s “Spooky Sips and Carving Clips” celebration! It was wonderful to gather, share some laughs, and carve out some creativity with our pumpkins. A big thanks to everyone for making it a fang-tastic experience! It’s always a hauntingly good time at Mediar! #PumpkinCarving #TeamSpirit

Join our Mediarities Colleen Graham, MBA, VP and Head of Clinical Operations and Katherine Palu, Clinical Trial Associate at Outsourcing in Clinical Trials New England. This year's event spans key areas in clinical research: streamlining operations and partnerships, embracing innovative technologies, advancing rare disease studies,?and enhancing patient engagement and recruitment strategies. Learn how Mediar is pushing biotech boundaries as Colleen takes the stage for both a presentation and a panel discussion, offering expert insights on the latest in clinical operations. Looking forward to seeing you there! #OCTNE2024 #ClinicalTrials #Biotech

Happy 5-year anniversary, Christopher Espelin, PhD! Your talent and dedication have shaped our team and left a lasting mark.??? We’re beyond grateful for your hard work and excited for what’s next as we keep pushing boundaries together! #TeamAnniversaries #WorkMilestones #EmployeeAppreciation #CompanyCulture #biotech

Mediar’s Colleen Graham, MBA, Vice President and Head of Clinical Operations, will join other clinical operations executives and experts later this week in beautiful Cape Cod at the Clinical Operations Retreat for Executives (CORE), hosted by Halloran Consulting Group, Inc. Get ready for a deep dive into clinical operations, from the earliest stages to successful completion. This panel promises valuable insights from seasoned professionals who have navigated the complexities of clinical development. For more details, visit: https://lnkd.in/d3_KdK2A #Biotech #CORE2024

?? ?? ?? Fall vibes = good times! The Mediar team enjoyed a colorful Fall Fiesta, filled with delicious eats, laughter, and fun! These #MediarMoments capture the energy and excitement of coming together, reminding us how much we value connection and camaraderie as we keep the party—and our team spirit—going strong.

Today, we’re celebrating two incredible Mediarites who help power our progress! ?? Gabby Dower, PhD, has been an integral part of the Mediar team for four years, leading conference initiatives and overseeing preclinical efforts. Allie M. Roach, M.Sc., ALM joined us last year, bringing a background in preclinical research and sharp insights to our programs. From all of us at Mediar, thank you for your passion and dedication! #TeamAnniversaries #WorkMilestones #EmployeeAppreciation #CompanyCulture #biotech

The Mediar team got a head start on Pulmonary Fibrosis Foundation's National PF Walk Day, uniting in solidarity in the fight against pulmonary #fibrosis.?Together, we walked with purpose – not just for improved treatments, but for a future free from this life-threatening condition. With each step, we raised awareness of a cause that impacts so many patients, families and caregivers, renewing hope toward a cure. Every breath counts! ? #PFFWalk #PulmonaryFibrosis #WalkForACure #PFAM

Mediar Therapeutics is staying local in the heart of biotech for the Mass General Brigham World Medical Innovation Forum, spotlighting cutting-edge advancements in inflammation and immunology, oncology, and rare diseases. Our CEO Rahul Ballal, PhD, will share valuable insights and perspectives during the Healthcare Corporate Venture panel discussion. We look forward to seeing you there! For more info: https://lnkd.in/eGbwFMCA #WMIF2024 #HealthcareInnovation #Biotech